JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
TTSH
4776
DELISTED
Tile Shop Holdings
TTSH
| $77K | ﹤0.01% |
13,605
+195
| +1% | +$1.27K |
2016 Q3
10 quarters
|
|
|
RESP
4777
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $77K | ﹤0.01% |
2,373
| – | – |
2018 Q2
3 quarters
|
|
|
CALA
4778
DELISTED
Calithera Biosciences, Inc
CALA
| $77K | ﹤0.01% |
571
+174
| +44% | +$18.3K |
2017 Q4
5 quarters
|
|
|
EMCI
4779
DELISTED
EMC INS Group Inc
EMCI
| $77K | ﹤0.01% |
2,397
-4,489
| -65% | -$143K |
2016 Q4
9 quarters
|
|
4780
AC Immune
ACIU
$269M
| $76K | ﹤0.01% |
+15,049
| New | +$95.7K |
2019 Q1
0 quarters
|
|
4781
Peoples Financial Services
PFIS
$692M
| $76K | ﹤0.01% |
1,681
-572
| -25% | -$24.9K |
2017 Q4
5 quarters
|
|
4782
SIGA Technologies
SIGA
$250M
| $76K | ﹤0.01% |
12,665
-596
| -4% | -$4K |
2018 Q1
4 quarters
|
|
|
CCXI
4783
DELISTED
ChemoCentryx, Inc.
CCXI
| $76K | ﹤0.01% |
5,481
-257
| -4% | -$2.94K |
2017 Q4
5 quarters
|
|
4784
John Hancock Multifactor Large Cap ETF
JHML
$1.18B
| $75K | ﹤0.01% |
2,056
-16,638
| -89% | -$582K |
2017 Q2
7 quarters
|
|
|
CATC
4785
DELISTED
CAMBRIDGE BANCORP
CATC
| $75K | ﹤0.01% |
901
-193
| -18% | -$15.4K |
2018 Q2
3 quarters
|
|
|
ABDC
4786
DELISTED
Alcentra Capital Corp
ABDC
| $75K | ﹤0.01% |
+10,043
| New | +$72.5K |
2019 Q1
0 quarters
|
|
|
TACO
4787
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $75K | ﹤0.01% |
7,446
-349
| -4% | -$3.63K |
2017 Q4
5 quarters
|
|
4788
Civista Bancshares
CIVB
$558M
| $74K | ﹤0.01% |
3,410
-106
| -3% | -$2.1K |
2016 Q4
9 quarters
|
|
4789
J. Jill
JILL
$366M
| $74K | ﹤0.01% |
2,679
+1,612
| +151% | +$41.2K |
2017 Q4
5 quarters
|
|
4790
Coca-Cola Femsa
KOF
$22.7B
| $74K | ﹤0.01% |
1,116
-9,531
| -90% | -$597K |
2015 Q1
16 quarters
|
|
|
MOFG
4791
DELISTED
MidWestOne Financial Group
MOFG
| $74K | ﹤0.01% |
2,722
-128
| -4% | -$3.64K |
2016 Q4
9 quarters
|
|
4792
PUT
Under Armour Class C
UA
$1.96B
| $74K | ﹤0.01% |
+3,900
| New | +$73.7K |
2019 Q1
0 quarters
|
|
|
AAIC
4793
DELISTED
Arlington Asset Investment Corp.
AAIC
| $74K | ﹤0.01% |
9,308
-61,846
| -87% | -$511K |
2013 Q2
23 quarters
|
|
|
DFRG
4794
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $74K | ﹤0.01% |
11,570
-379
| -3% | -$2.99K |
2015 Q2
15 quarters
|
|
|
BSCM
4795
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $74K | ﹤0.01% |
3,516
+3,151
| +863% | +$65.8K |
2018 Q4
1 quarter
|
|
4796
Byline Bancorp
BY
$1.7B
| $73K | ﹤0.01% |
3,977
-186
| -4% | -$3.5K |
2017 Q4
5 quarters
|
|
4797
GSI Technology
GSIT
$217M
| $73K | ﹤0.01% |
9,441
-262
| -3% | -$2.01K |
2017 Q4
5 quarters
|
|
4798
Lifecore Biomedical
LFCR
$247M
| $73K | ﹤0.01% |
5,938
-987
| -14% | -$12K |
2017 Q4
5 quarters
|
|
4799
CALL
Viking Therapeutics
VKTX
$3.68B
| $73K | ﹤0.01% |
+7,300
| New | +$61.1K |
2019 Q1
0 quarters
|
|
|
TBIO
4800
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $73K | ﹤0.01% |
7,175
+4,670
| +186% | +$35.8K |
2018 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.